查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2001061

腎結石清除設備市場：2026-2032年全球市場預測（依產品類型、治療方法、治療模式、結石類型、最終用戶和通路分類）

Kidney Stone Retrieval Devices Market by Product Type, Treatment, Treatment Modality, Stone Type, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，腎結石清除設備市場價值將達到 25 億美元，到 2026 年將成長至 26.4 億美元，到 2032 年將達到 37.3 億美元，複合年成長率為 5.89%。

主要市場統計數據
基準年 2025 25億美元
預計年份：2026年 26.4億美元
預測年份：2032年 37.3億美元
複合年成長率 (%) 5.89%

本節概述了促進腎結石清除設備引入的技術、臨床和採購背景，提供了詳細的、基於臨床的介紹。

腎結石清除器械在泌尿系統、生物醫學工程和醫療系統採購這三大領域中佔據著至關重要的地位。臨床醫生依靠不斷擴充的醫療設備工具箱，在最大限度減少創傷和保護腎功能的同時，精準地清除結石。因此，如今的醫療設備設計決策需要同時兼顧臨床性能指標、手術容量目標以及病患體驗和手術安全性的日益成長的期望。隨著醫院和門診診所不斷最佳化其診療路徑，採購負責人和臨床負責人需要就器械選擇標準達成一致，以平衡耐用性、一次性使用性和與現有影像內視鏡平台的兼容性。

本文清晰地說明了正在重塑腎結石清除領域的臨床實踐、採購邏輯和競爭差異化的關鍵技術和醫療保健服務變革。

一場變革浪潮正在重新定義腎結石的診斷、碎石和取出方式，加速了從以單一器械為中心的治療模式轉向綜合臨床解決方案的轉變。光學元件和內視鏡的微型化，以及高解析度成像和碎石能量傳輸技術的進步，使得在保持臨床療效的同時，能夠以微創方式進入複雜的解剖結構。同時，在感染控制和簡化工作流程的需求推動下，一次性產品的興起促使供應商重新思考生產製造、消毒流程和供應物流。

對 2025 年美國關稅變化對供應鏈、採購和籌資策略。

2025年實施的關稅措施進一步增加了醫療設備製造商和臨床應用機構的供應鏈和籌資策略的複雜性。以往專注於最佳化成本和前置作業時間的籌資策略，如今面臨新的獎勵，例如供應商多元化、審查合約條款以及評估本地生產和近岸外包等風險緩解措施。依賴全球採購零件的醫療設備製造商被迫重新評估供應商集中度和物流計劃，而醫療系統則被迫在轉嫁成本和維持短期庫存以確保治療連續性之間做出抉擇。

根據產品類型、臨床治療、治療方式、結石成分、最終用戶和分銷管道，優先考慮商業化，並提供可操作的見解。

市場區隔揭示了清晰的部署模式和決策因素，這些因素指南產品策略和臨床實施。根據產品類型，臨床醫生需要在體外震波碎石機、取石籃、輸尿管支架和輸尿管鏡之間權衡利弊。每類產品都需要特定的屬性，例如效能、一次性使用性和相容性，這些屬性會影響採購週期和培訓投入。根據治療方法，體外震波碎石術、經皮鏡取石術或輸尿管鏡檢查等臨床途徑決定了醫療設備的選擇、相關的資本投資需求和治療人員配備，從而影響醫院和門診中心如何優先考慮資本投資。

透過深入的區域分析，我們可以了解美洲、歐洲、中東和非洲以及亞太地區的趨勢如何推動供應鏈策略的採用、監管和差異化。

區域趨勢對微創技術的普及曲線、報銷機制和供應鏈結構有顯著影響。在美洲，先進的醫院網路和門診手術中心推動了微創技術的快速普及，而報銷政策和臨床培訓計畫則支持了向門診治療的轉變。在這種環境下，能夠與現有內視鏡平台整合並在處理能力和安全性方面展現優勢的醫療設備更受青睞。相較之下，歐洲、中東和非洲的監管和報銷情況則更為多元。雖然一些市場強調集中採購和基於價值的競標，但其他市場仍然存在基礎設施和准入方面的限制，這為靈活的資金籌措模式和模組化器械平台創造了機會。

專注於醫療設備市場的臨床證據、供應鏈彈性、整合服務模式和夥伴關係主導成長的企業級策略洞察。

腎結石清除設備領域的企業正朝著幾個務實的目標邁進：透過可靠的臨床證據展現差異化優勢，確保穩定的供應鏈，並將服務範圍擴展到一次性設備銷售之外。擁有涵蓋資本設備、耗材和一次性產品的均衡產品組合的企業，能夠滿足醫療服務流程中的多個環節，從而深化客戶關係並最佳化收入週期。與影像設備供應商、能源供應專家和臨床培訓合作夥伴建立策略夥伴關係，正成為加速產品部署和建構一體化治療方案的有效途徑，使醫療機構更容易證明其應用的合理性。

為製造商、供應商和醫療保健系統提供實用且優先的建議，以加快腎結石清除技術的採用，降低風險，並確保商業性優勢。

行業領導企業應採取一系列互補舉措，在促進臨床應用的同時，保護利潤率和聲譽。首先，投資產生臨床證據，將設備性能與治療效率、併發症減少和患者報告結果聯繫起來，從而為保險公司和醫療保健系統提供更強大的價值提案。其次，重新設計價值鏈結構，納入合約保障措施，以降低多元化、區域組裝、關稅風險和物流中斷等風險。第三，發展靈活的商業模式和資金籌措方案，以適應不同終端使用者（例如醫院、門診中心和診所）多樣化的採購週期。

對混合方法檢驗研究途徑進行了透明而嚴謹的概述，該方法整合了臨床醫生訪談、文獻整合、醫療設備註冊分析和三角通訊協定。

本分析的調查方法結合了定性研究、有針對性的定量檢驗以及嚴謹的二手資料，以確保分析的穩健性和有效性。一手資料包括對泌尿系統、採購經理和醫療設備工程師的結構化訪談，並輔以諮詢小組的意見，該小組檢驗臨床假設並確定未滿足需求的優先順序。二手研究則利用了同行評審的臨床文獻、醫療設備註冊資訊、監管申報文件和公共衛生資料集，以支持對手術流程、醫療設備性能特徵和政策變化趨勢的分析。

簡潔而前瞻性的結論，整合了決定該領域持續成功的技術、臨床和商業性要求。

總之，腎結石清除器材的市場環境正快速演變，受到技術創新、醫療模式轉變和商業性因素波動的影響。小型化、成像和一次性技術的進步正在拓展治療選擇，同時也帶來了永續性、供應可靠性和採購誠信的新挑戰。 2025年的定價環境進一步凸顯了全球採購體系的脆弱性，也使得策略價值鏈設計的重要性日益凸顯。能夠在這種環境下蓬勃發展的相關人員，很可能是那些能夠將臨床證據與營運價值提案、靈活的商業模式和具有韌性的製造地相結合的公司。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：腎結石清除設備市場：依產品類型分類

  • 破碎設備
  • 石塊移除籃
  • 輸尿管支架
  • 輸尿管鏡

第9章 腎結石清除設備市場：依治療方法

  • 體外震波碎石術
  • 經皮皮腎結石切除術
  • 輸尿管鏡治療

第10章：腎結石清除設備市場：依治療方法分類

  • 微創手術
  • 非侵入性手術
  • 開放式/傳統手術

第11章：腎結石取出設備市場：依結石類型分類

  • 鈣結石
  • 胱氨酸結石
  • 鳥糞石
  • 尿酸結石

第12章：腎結石清除設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第13章：腎結石清除設備市場：依通路分類

  • 離線
  • 線上

第14章 腎結石清除設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：腎結石取出設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：腎結石清除設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國腎結石清除設備市場

第18章：中國腎結石清除設備市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allengers Medical Systems Limited
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Coloplast A/S
  • CONMED Corporation
  • Cook Medical LLC
  • DCC plc
  • Dornier MedTech GmbH
  • KARL STORZ SE & Co. KG
  • MED-Fibers, Inc
  • Medtronic plc
  • Olympus Corporation
  • Quanta System SpA
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • STORZ MEDICAL AG
  • Stryker Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • Walz Elektronik GmbH
Product Code: MRR-F927BA461C2E

The Kidney Stone Retrieval Devices Market was valued at USD 2.50 billion in 2025 and is projected to grow to USD 2.64 billion in 2026, with a CAGR of 5.89%, reaching USD 3.73 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.50 billion
Estimated Year [2026] USD 2.64 billion
Forecast Year [2032] USD 3.73 billion
CAGR (%) 5.89%

A thoughtful and clinically grounded introduction that frames the technological, clinical, and procurement context driving kidney stone retrieval device adoption

Kidney stone retrieval devices occupy a pivotal position at the intersection of urology, biomedical engineering, and health systems procurement. Clinicians rely on an expanding toolkit of devices to extract calculi with precision while minimizing trauma and preserving renal function. Consequently, device design decisions now respond simultaneously to clinical performance metrics, procedure throughput targets, and growing expectations around patient experience and procedural safety. As hospitals and ambulatory settings refine care pathways, procurement stakeholders and clinical leaders must align on device selection criteria that balance durability, disposability, and compatibility with existing imaging and endoscopic platforms.

Over recent years, iterative advances in optics, material science, and ergonomic design have reshaped the available options for stone removal, enabling clinicians to tackle an increasingly diverse case mix across stone composition and anatomical complexity. This evolution occurs alongside changes in care delivery, where the migration of appropriate procedures to outpatient environments requires devices that reduce procedure time and support rapid recovery. Therefore, stakeholders should view device choice not only as a clinical enabler but also as a lever for operational efficiency, patient throughput, and reimbursement alignment. As such, a holistic introduction to this space must consider the clinical imperatives, the technological enablers, and the organizational constraints that collectively determine adoption and sustained utilization.

Clear exposition of the major technological and care delivery shifts that are reshaping clinical practice, procurement logic, and competitive differentiation in kidney stone retrieval

A wave of transformative shifts is redefining how kidney stones are diagnosed, fragmented, and removed, accelerating the transition from single-discipline device thinking to integrated clinical solutions. Miniaturization of optics and scopes, coupled with high-definition imaging and improved lithotripsy energy delivery, has enabled less invasive access to complex anatomies while preserving clinical outcomes. In parallel, the rise of single-use disposables responds to infection-control priorities and workflow simplicity, prompting vendors to rethink manufacturing, sterilization burden, and supply logistics.

Beyond hardware, software-driven enhancements are creating new value layers: intraoperative imaging fusion, augmented visualization, and procedural analytics increasingly support clinician decision-making and training. These capabilities dovetail with broader healthcare priorities such as value-based care and outpatient migration, where faster procedures, predictable device performance, and lower reprocessing demands matter. Additionally, environmental and sustainability concerns are influencing procurement dialogues, requiring manufacturers and providers to balance device lifecycle impacts with clinical benefit. Taken together, these forces are shifting competitive dynamics, with innovation as the differentiator for firms that can demonstrate clinical evidence, operational advantage, and supply reliability.

In-depth analysis of the cascading operational and commercial consequences following the 2025 United States tariff changes affecting supply chain, sourcing, and procurement strategies

The introduction of tariff measures in the United States in 2025 has layered additional complexity onto supply chains and procurement strategies for device manufacturers and clinical adopters. Sourcing strategies that previously optimized for cost and lead time now face new incentives to diversify supplier bases, revisit contract terms, and evaluate localized manufacturing or nearshoring as risk mitigation pathways. Device makers that depend on globally sourced components have had to reassess supplier concentration and logistics plans, while health systems have confronted decisions about pass-through costs versus short-term stockpiling to preserve procedural continuity.

Regulatory compliance and documentation requirements have assumed greater prominence as customs scrutiny increased, making import classification and validation of manufacturing sites central to commercial planning. In response, several stakeholders accelerated partnerships with domestic contract manufacturers and recalibrated inventory strategies to reduce exposure to tariff volatility. At the same time, higher landed costs for certain components have created pressure to optimize product portfolios; manufacturers prioritized higher-margin or higher-volume SKUs and incrementally adjusted design and material choices where clinically acceptable. For purchasers, the tariff environment underscored the value of multi-year supply agreements with price-protection clauses and closer collaboration with vendors on total cost of ownership, thereby integrating procurement and clinical planning more tightly than before.

Actionable segmentation-driven insights that map product types, clinical treatments, modalities, stone compositions, end users, and distribution channels to commercialization priorities

Segmentation reveals distinct adoption patterns and decision drivers that inform product strategy and clinical deployment. Based on Product Type, clinicians weigh the trade-offs among lithotripters, stone removal baskets, ureteral stents, and ureteroscopes, with each category demanding specific performance, disposability, and compatibility attributes that influence purchasing cycles and training investments. Based on Treatment, the clinical pathway-whether extracorporeal shock wave lithotripsy, percutaneous nephrolithotomy, or ureteroscopy-shapes device selection, ancillary capital needs, and procedural staffing models, thereby affecting how hospitals and outpatient centers prioritize capital allocation.

Based on Treatment Modality, the rise of minimally invasive procedures over non-invasive or open surgeries has prompted device makers to focus on miniaturized, precision-oriented tools and adjuncts that reduce collateral tissue impact and support rapid recovery. Based on Stone Type, variations in calcium stones, cystine stones, struvite stones, and uric acid stones drive differences in energy delivery preferences, basket design, and stent selection, which in turn dictate clinician training and inventory diversity. Based on End User, ambulatory surgical centers, clinics, and hospitals exhibit divergent procurement processes, budget cycles, and staffing competencies, so manufacturers must tailor commercial models and service offerings accordingly. Based on Distribution Channel, the coexistence of offline and online channels has introduced new routes-to-market: traditional surgical distributors remain critical for complex capital equipment and bundled services, while online channels enable consumable distribution and flexible replenishment for high-volume items. Taken together, segmentation provides a roadmap for aligning R&D, marketing, and sales strategies to clinical realities and procurement constraints.

Informed regional intelligence highlighting how the Americas, Europe Middle East & Africa, and Asia-Pacific dynamics drive differentiated adoption, regulatory, and supply chain strategies

Regional dynamics materially influence adoption curves, reimbursement frameworks, and supply chain architectures. In the Americas, advanced hospital networks and ambulatory surgery centers have driven rapid uptake of minimally invasive technologies, with reimbursement policies and clinician training programs supporting outpatient migration. This environment favors devices that integrate with existing endoscopic platforms and that demonstrate throughput and safety advantages. In contrast, Europe, Middle East & Africa present a heterogeneous regulatory and reimbursement landscape; certain markets emphasize centralized procurement and value-based tendering while others remain constrained by infrastructure and access, creating opportunities for flexible financing models and modular device platforms.

Asia-Pacific displays differentiated demand drivers across mature and emerging markets, with strong manufacturing ecosystems in some countries and rapid clinical adoption in urban centers. Regulatory harmonization efforts and local manufacturing incentives are shaping vendor strategies, while clinicians increasingly expect evidence of long-term safety and procedural effectiveness. Cross-region, logistical considerations and tariff policies have prompted manufacturers to balance centralized production with regionalized assembly or contract manufacturing to optimize lead times and compliance. Ultimately, successful regional strategies combine clinical evidence generation, tailored commercial approaches, and resilient supply arrangements to meet diverse payer and provider expectations.

Strategic company-level insights emphasizing clinical evidence, supply resilience, integrated service models, and partnership-driven growth in the device landscape

Company strategies within the kidney stone retrieval device space are converging on a few pragmatic priorities: demonstrate clinical differentiation through robust evidence, secure reliable supply chains, and broaden service offerings that extend beyond one-off device sales. Firms with balanced portfolios that include capital equipment, consumables, and disposable options can address multiple points in the care pathway, thereby deepening customer relationships and smoothing revenue cycles. Strategic collaborations with imaging vendors, energy delivery specialists, and clinical training partners have emerged as a means to accelerate adoption and to create integrated procedural solutions that are easier for institutions to justify.

Mergers, acquisitions, and targeted partnerships remain tools for acquiring niche technologies, regulatory approvals, or distribution footprints, while organic investment in clinical studies supports payer negotiations and guideline inclusion. Additionally, firms are experimenting with alternative commercial models-subscription services, managed device programs, and bundled purchasing-to align incentives around outcomes and usage predictability. Manufacturers that prioritize modular design, interoperable systems, and strong post-market support stand to gain in procurement evaluations where total cost of ownership and procedure-level outcomes are increasingly salient. Finally, transparency in sourcing, manufacturing quality, and environmental footprint strengthens vendor credibility in procurement discussions that now extend beyond price alone.

Practical and prioritized recommendations for manufacturers, suppliers, and health systems to accelerate adoption, reduce risk, and secure commercial advantage in kidney stone retrieval

Industry leaders should pursue a set of complementary actions to capture clinical adoption while protecting margin and reputation. First, invest in clinical evidence generation that links device performance to procedural efficiency, complication reduction, and patient-reported outcomes, thereby enabling stronger value propositions for payers and health systems. Second, redesign supply chain architectures to incorporate multi-sourcing, regional assembly, and contractual protections that mitigate tariff exposure and logistics disruptions. Third, develop flexible commercial models and financing solutions that accommodate varied end-user procurement cycles across hospitals, ambulatory centers, and clinics.

Moreover, prioritize product modularity and interoperability to ease integration with imaging, energy delivery, and documentation systems, facilitating faster adoption and reducing training burden. Enhance clinician support through simulation-based training and proctoring programs that lower procedural variability and accelerate competence with new devices. Simultaneously, integrate sustainability considerations into product life-cycle planning to address procurement criteria beyond cost and clinical performance. Finally, cultivate deep partnerships with payers, large health systems, and professional societies to align evidence generation with guideline development and reimbursement pathways, thereby turning clinical differentiation into durable commercial advantage.

Transparent and rigorous overview of the mixed-methods research approach integrating clinician interviews, literature synthesis, device registry analysis, and triangulation protocols

The research methodologies underpinning this analysis combined primary qualitative inquiry, targeted quantitative validation, and rigorous secondary-source synthesis to ensure robustness and relevance. Primary inputs included structured interviews with urologists, procurement leaders, and device engineers, complemented by advisory panels that validated clinical assumptions and prioritized unmet needs. Secondary research drew on peer-reviewed clinical literature, device registries, regulatory filings, and public health datasets to corroborate procedural trends, device performance characteristics, and policy shifts.

Analytical processes emphasized triangulation across data streams, conflict resolution of divergent inputs, and scenario testing for sensitivity to supply chain or policy shocks. Data quality protocols included source traceability, interview transcriptions, and cross-validation with multiple clinician respondents to reduce bias. Where primary evidence was limited, the methodology relied on consensus among subject-matter experts and transparent documentation of assumptions. Limitations are acknowledged in areas where long-term outcomes data remain scarce, and the study recommends continuous evidence updates as new clinical studies and real-world registries emerge.

Concise and forward-looking conclusion synthesizing technological, clinical, and commercial imperatives that will determine sustained success in the sector

In conclusion, the kidney stone retrieval device landscape is evolving rapidly under the influence of technological innovation, changing care models, and shifting commercial forces. Advances in miniaturization, imaging, and disposable technologies are expanding procedural options while raising new questions about sustainability, supply reliability, and procurement alignment. The 2025 tariff environment further highlighted the fragility of global sourcing and elevated the importance of strategic supply chain design. Stakeholders that successfully navigate this landscape will be those who pair clinical evidence with operational value propositions, flexible commercial models, and resilient manufacturing footprints.

Looking ahead, coordinated action among manufacturers, health systems, and payers will be essential to translate device innovation into measurable improvements in patient outcomes and care efficiency. Continued investment in clinical validation, clinician training, and regionally appropriate supply solutions will underpin durable adoption. Ultimately, a pragmatic focus on interoperability, lifecycle cost, and real-world performance will determine which technologies realize sustained clinical and commercial success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Kidney Stone Retrieval Devices Market, by Product Type

  • 8.1. Lithotripters
  • 8.2. Stone Removal Baskets
  • 8.3. Ureteral Stents
  • 8.4. Ureteroscopes

9. Kidney Stone Retrieval Devices Market, by Treatment

  • 9.1. Extracorporeal Shock Wave Lithotripsy
  • 9.2. Percutaneous Nephrolithotomy
  • 9.3. Ureteroscopy

10. Kidney Stone Retrieval Devices Market, by Treatment Modality

  • 10.1. Minimally Invasive Procedures
  • 10.2. Non-Invasive Procedures
  • 10.3. Open/Conventional Surgeries

11. Kidney Stone Retrieval Devices Market, by Stone Type

  • 11.1. Calcium Stones
  • 11.2. Cystine Stones
  • 11.3. Struvite Stones
  • 11.4. Uric Acid Stones

12. Kidney Stone Retrieval Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Kidney Stone Retrieval Devices Market, by Distribution Channel

  • 13.1. Offline
  • 13.2. Online

14. Kidney Stone Retrieval Devices Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Kidney Stone Retrieval Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Kidney Stone Retrieval Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Kidney Stone Retrieval Devices Market

18. China Kidney Stone Retrieval Devices Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Allengers Medical Systems Limited
  • 19.6. Becton, Dickinson and Company
  • 19.7. Boston Scientific Corporation
  • 19.8. Cardinal Health, Inc.
  • 19.9. Coloplast A/S
  • 19.10. CONMED Corporation
  • 19.11. Cook Medical LLC
  • 19.12. DCC plc
  • 19.13. Dornier MedTech GmbH
  • 19.14. KARL STORZ SE & Co. KG
  • 19.15. MED-Fibers, Inc
  • 19.16. Medtronic plc
  • 19.17. Olympus Corporation
  • 19.18. Quanta System S.p.A.
  • 19.19. Richard Wolf GmbH
  • 19.20. Siemens Healthineers AG
  • 19.21. STORZ MEDICAL AG
  • 19.22. Stryker Corporation
  • 19.23. Stryker Corporation
  • 19.24. Teleflex Incorporated
  • 19.25. Walz Elektronik GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY LITHOTRIPTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE REMOVAL BASKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE REMOVAL BASKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE REMOVAL BASKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETEROSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETEROSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URETEROSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY MINIMALLY INVASIVE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY NON-INVASIVE PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY OPEN/CONVENTIONAL SURGERIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY OPEN/CONVENTIONAL SURGERIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY OPEN/CONVENTIONAL SURGERIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CALCIUM STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CALCIUM STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CALCIUM STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CYSTINE STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CYSTINE STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CYSTINE STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STRUVITE STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STRUVITE STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STRUVITE STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URIC ACID STONES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URIC ACID STONES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY URIC ACID STONES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. GCC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. GCC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 133. GCC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GCC KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. G7 KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. G7 KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 154. G7 KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. G7 KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. NATO KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. NATO KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 161. NATO KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. NATO KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY TREATMENT MODALITY, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY STONE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA KIDNEY STONE RETRIEVAL DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)